Patents by Inventor Pajhand Iranitalab

Pajhand Iranitalab has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11806073
    Abstract: Systems, devices, and methods for transvascular ablation of target tissue. The devices and methods may, in some examples, be used for splanchnic nerve ablation to increase splanchnic venous blood capacitance to treat at least one of heart failure and hypertension. For example, the devices disclosed herein may be advanced endovascularly to a target vessel in the region of a thoracic splanchnic nerve (TSN), such as a greater splanchnic nerve (GSN) or a TSN nerve root. Also disclosed are methods of treating heart failure, such as HFpEF, by endovascularly ablating a thoracic splanchnic nerve to increase venous capacitance and reduce pulmonary blood pressure.
    Type: Grant
    Filed: October 22, 2021
    Date of Patent: November 7, 2023
    Assignee: Axon Therapies, Inc.
    Inventors: Anisha Bapna, Zoar Jacob Engelman, Howard Levin, Pajhand Iranitalab, Casey Andrew Miller, Thomas Ryan McGrath, Manuel Arzadon Javier, Jr.
  • Publication number: 20230165634
    Abstract: Systems, devices, and methods for transvascular ablation of target tissue. The devices and methods may, in some examples, be used for splanchnic nerve ablation to increase splanchnic venous blood capacitance to treat at least one of heart failure and hypertension. For example, the devices disclosed herein may be advanced endovascularly to a target vessel in the region of a thoracic splanchnic nerve (TSN), such as a greater splanchnic nerve (GSN) or a TSN nerve root. Also disclosed are methods of treating heart failure, such as HFpEF, by endovascularly ablating a thoracic splanchnic nerve to increase venous capacitance and reduce pulmonary blood pressure.
    Type: Application
    Filed: November 21, 2022
    Publication date: June 1, 2023
    Inventors: Pajhand IRANITALAB, Casey Andrew MILLER, Thomas Ryan McGRATH, Manuel Arzadon JAVIER, Anisha BAPNA, Zoar Jacob ENGELMAN, Howard LEVIN, Nicholas C. VanDILLEN, Anne Marie AHONEN
  • Patent number: 11504185
    Abstract: Systems, devices, and methods for transvascular ablation of target tissue. The devices and methods may, in some examples, be used for splanchnic nerve ablation to increase splanchnic venous blood capacitance to treat at least one of heart failure and hypertension. For example, the devices disclosed herein may be advanced endovascularly to a target vessel in the region of a thoracic splanchnic nerve (TSN), such as a greater splanchnic nerve (GSN) or a TSN nerve root. Also disclosed are methods of treating heart failure, such as HFpEF, by endovascularly ablating a thoracic splanchnic nerve to increase venous capacitance and reduce pulmonary blood pressure.
    Type: Grant
    Filed: June 11, 2021
    Date of Patent: November 22, 2022
    Assignee: Axon Therapies, Inc.
    Inventors: Pajhand Iranitalab, Casey Andrew Miller, Thomas Ryan McGrath, Manuel Arzadon Javier, Anisha Bapna, Zoar Jacob Engelman, Howard Levin, Nicholas C. VanDillen, Anne Marie Ahonen
  • Patent number: 11413090
    Abstract: Systems, devices, and methods for transvascular ablation of target tissue. The devices and methods may, in some examples, be used for splanchnic nerve ablation to increase splanchnic venous blood capacitance to treat at least one of heart failure and hypertension. For example, the devices disclosed herein may be advanced endovascularly to a target vessel in the region of a thoracic splanchnic nerve (TSN), such as a greater splanchnic nerve (GSN) or a TSN nerve root. Also disclosed are methods of treating heart failure, such as HFpEF, by endovascularly ablating a thoracic splanchnic nerve to increase venous capacitance and reduce pulmonary blood pressure.
    Type: Grant
    Filed: January 19, 2021
    Date of Patent: August 16, 2022
    Assignee: Axon Therapies, Inc.
    Inventors: Pajhand Iranitalab, Casey Andrew Miller, Thomas Ryan McGrath, Manuel Arzadon Javier, Jr., Anisha Bapna, Zoar Jacob Engelman, Howard Levin, Nicholas C. VanDillen, Anne Marie Ahonen
  • Publication number: 20220039863
    Abstract: Systems, devices, and methods for transvascular ablation of target tissue. The devices and methods may, in some examples, be used for splanchnic nerve ablation to increase splanchnic venous blood capacitance to treat at least one of heart failure and hypertension. For example, the devices disclosed herein may be advanced endovascularly to a target vessel in the region of a thoracic splanchnic nerve (TSN), such as a greater splanchnic nerve (GSN) or a TSN nerve root. Also disclosed are methods of treating heart failure, such as HFpEF, by endovascularly ablating a thoracic splanchnic nerve to increase venous capacitance and reduce pulmonary blood pressure.
    Type: Application
    Filed: October 22, 2021
    Publication date: February 10, 2022
    Inventors: Anisha BAPNA, Zoar Jacob ENGELMAN, Howard LEVIN, Pajhand IRANITALAB, Casey Andrew MILLER, Thomas Ryan MCGRATH, Manuel Arzadon JAVIER, JR.
  • Publication number: 20210298824
    Abstract: Systems, devices, and methods for transvascular ablation of target tissue. The devices and methods may, in some examples, be used for splanchnic nerve ablation to increase splanchnic venous blood capacitance to treat at least one of heart failure and hypertension. For example, the devices disclosed herein may be advanced endovascularly to a target vessel in the region of a thoracic splanchnic nerve (TSN), such as a greater splanchnic nerve (GSN) or a TSN nerve root. Also disclosed are methods of treating heart failure, such as HFpEF, by endovascularly ablating a thoracic splanchnic nerve to increase venous capacitance and reduce pulmonary blood pressure.
    Type: Application
    Filed: June 11, 2021
    Publication date: September 30, 2021
    Inventors: Pajhand IRANITALAB, Casey Andrew MILLER, Thomas Ryan McGRATH, Manuel Arzadon JAVIER, Anisha BAPNA, Zoar Jacob ENGELMAN, Howard LEVIN, Nicholas C. VanDILLEN, Anne Marie AHONEN
  • Publication number: 20210220043
    Abstract: Systems, devices, and methods for transvascular ablation of target tissue. The devices and methods may, in some examples, be used for splanchnic nerve ablation to increase splanchnic venous blood capacitance to treat at least one of heart failure and hypertension. For example, the devices disclosed herein may be advanced endovascularly to a target vessel in the region of a thoracic splanchnic nerve (TSN), such as a greater splanchnic nerve (GSN) or a TSN nerve root. Also disclosed are methods of treating heart failure, such as HFpEF, by endovascularly ablating a thoracic splanchnic nerve to increase venous capacitance and reduce pulmonary blood pressure.
    Type: Application
    Filed: January 19, 2021
    Publication date: July 22, 2021
    Inventors: Pajhand IRANITALAB, Casey Andrew MILLER, Thomas Ryan McGRATH, Manuel Arzadon JAVIER, JR., Anisha BAPNA, Zoar Jacob ENGELMAN, Howard LEVIN, Nicholas C. VanDILLEN, Anne Marie AHONEN
  • Patent number: 9233250
    Abstract: Embodiments of the present invention concern the timing of sending one or more commands to control circuitry of a multi-electrode lead (MEL). In one embodiment, the one or more commands are sent to control circuitry within the MEL during a predetermined portion of a cardiac pacing cycle to avoid potential problems of prior systems that were not synchronized with the cardiac pacing cycle. In one embodiment, the one or more commands are sent when cardiac tissue is refractory from a cardiac pacing pulse, to prevent the command(s) from potentially undesirably stimulating cardiac tissue. The command sending can occur such that the one or more commands are sent between instances when sensing circuitry of the implantable cardiac stimulation device is being used to obtain one or more signals indicative of cardiac electrical activity, to prevent interference between the one or more commands with the signals indicative of cardiac electrical activity that are sensed.
    Type: Grant
    Filed: December 29, 2009
    Date of Patent: January 12, 2016
    Assignee: Pacesetter, Inc.
    Inventors: Anne Shelchuk, Yongjian Wu, Chris Pontiga, April Pixley, Pajhand Iranitalab, Elisabeth M. Clem, Shohan Hossain, Jianchun Yi
  • Patent number: 9017279
    Abstract: An insufflator device is provided that connects to a disposable tube set for providing gas to fill an abdominal cavity of a patient to enable surgical procedures. The insufflator tube set includes a warming sheath, a double lumen design, or a heating strip for providing warmth to the insufflation gas being conveyed through the tube set. A method of heating insufflation gases is also provided.
    Type: Grant
    Filed: August 10, 2010
    Date of Patent: April 28, 2015
    Assignee: Stryker Corporation
    Inventors: Pajhand Iranitalab, Xiaodong Xiang
  • Patent number: 8366654
    Abstract: An insufflation device connects to a disposable tube set for providing gas to fill an abdominal cavity of a patient to enable surgical procedures. The insufflation device has an ultraviolet light source to provide ultraviolet light for sterilizing a flow control valve system therein. A filter provided with the insufflation device enables additional surgical procedures for the insufflation device without cleaning of the flow control valve systems or necessarily replacement of the filter. Tube sets connected to the insufflation device do not necessarily require a filter.
    Type: Grant
    Filed: August 10, 2010
    Date of Patent: February 5, 2013
    Assignee: Stryker Corporation
    Inventor: Pajhand Iranitalab
  • Publication number: 20120157985
    Abstract: An endometrial ablation apparatus is provided which includes an end member with a plurality of electrodes. The probe is attached to a controller that includes a multiplexer capable of activating each electrode individually or multiple electrodes simultaneously, such that each individual electrode may be energized separately in series to complete the ablation process. A method of performing ablation using such an apparatus is also provided.
    Type: Application
    Filed: December 16, 2011
    Publication date: June 21, 2012
    Inventors: Lisa M. BALLOU, Melissa D. Caputo, Pajhand Iranitalab, Xiaodong Xiang
  • Patent number: 8180456
    Abstract: Methods and systems are provided for configuring a Multi-Electrode Lead (MEL) that includes N groups of electrodes, with each of the N groups of electrodes including at least M electrodes, where N?2 and M?2. Sent via the MEL is a first communication sequence of bits that includes N groups of bits, with each of the N groups of bits corresponding to a different one of the N groups of electrodes and specifying which electrode(s), if any, within the group of electrodes is to be configured as an anode. Also sent via the MEL is a second communication sequence of bits that includes N further groups of bits, with each of the N further groups of bits corresponding to a different one of the N groups of electrodes and specifying which electrode(s), if any, within the group of electrodes is to be configured as a cathode.
    Type: Grant
    Filed: August 7, 2009
    Date of Patent: May 15, 2012
    Assignee: Pacesetter, Inc.
    Inventors: Christopher Pontiga, Youngjian Wu, Pajhand Iranitalab, April Pixley
  • Publication number: 20110082416
    Abstract: An insufflator device is provided that connects to a disposable tube set for providing gas to fill an abdominal cavity of a patient to enable surgical procedures. The insufflator tube set includes a warming sheath, a double lumen design, or a heating strip for providing warmth to the insufflation gas being conveyed through the tube set. A method of heating insufflation gases is also provided.
    Type: Application
    Filed: August 10, 2010
    Publication date: April 7, 2011
    Inventors: Pajhand Iranitalab, Xiaodong Xiang
  • Publication number: 20110060272
    Abstract: An insufflation device connects to a disposable tube set for providing gas to fill an abdominal cavity of a patient to enable surgical procedures. The insufflation device has an ultraviolet light source to provide ultraviolet light for sterilizing a flow control valve system therein. A filter provided with the insufflation device enables additional surgical procedures for the insufflation device without cleaning of the flow control valve systems or necessarily replacement of the filter. Tube sets connected to the insufflation device do not necessarily require a filter.
    Type: Application
    Filed: August 10, 2010
    Publication date: March 10, 2011
    Inventor: Pajhand Iranitalab
  • Publication number: 20110046690
    Abstract: Embodiments of the present invention concern the timing of sending one or more commands to control circuitry of a multi-electrode lead (MEL). In one embodiment, the one or more commands are sent to control circuitry within the MEL during a predetermined portion of a cardiac pacing cycle to avoid potential problems of prior systems that were not synchronized with the cardiac pacing cycle. In one embodiment, the one or more commands are sent when cardiac tissue is refractory from a cardiac pacing pulse, to prevent the command(s) from potentially undesirably stimulating cardiac tissue. The command sending can occur such that the one or more commands are sent between instances when sensing circuitry of the implantable cardiac stimulation device is being used to obtain one or more signals indicative of cardiac electrical activity, to prevent interference between the one or more commands with the signals indicative of cardiac electrical activity that are sensed.
    Type: Application
    Filed: December 29, 2009
    Publication date: February 24, 2011
    Inventors: Anne Shelchuk, Yonglian Wu, Chris Pontiga, April Pixley, Pajhand Iranitalab, Elisabeth M. Clem, Shohan Hossain, Jianchun Yi
  • Publication number: 20100312298
    Abstract: Methods and systems are provided for configuring a Multi-Electrode Lead (MEL) that includes N groups of electrodes, with each of the N groups of electrodes including at least M electrodes, where N?2 and M?2. Sent via the MEL is a first communication sequence of bits that includes N groups of bits, with each of the N groups of bits corresponding to a different one of the N groups of electrodes and specifying which electrode(s), if any, within the group of electrodes is to be configured as an anode. Also sent via the MEL is a second communication sequence of bits that includes N further groups of bits, with each of the N further groups of bits corresponding to a different one of the N groups of electrodes and specifying which electrode(s), if any, within the group of electrodes is to be configured as a cathode.
    Type: Application
    Filed: August 7, 2009
    Publication date: December 9, 2010
    Inventors: Christopher Pontiga, Youngjian Wu, Pajhand Iranitalab, April Pixley
  • Patent number: 7751886
    Abstract: An implantable stimulation device that maps the location of irritable foci causing an atrial arrhythmia is provided by certain embodiments disclosed herein. The device may, for example, collect intra-cardiac data from a plurality of electrodes spatially distributed throughout a chamber of the heart. This data may be compared with data related to the location of each electrode and the electrical properties of the heart to approximate a point of origin for the atrial arrhythmia. Further embodiments may provide methods and systems for using this information to provide more efficient treatment of the atrial arrhythmia. For example, an optimized ATP pulse train may be determined based on the location of one or more irritable foci. Such an ATP pulse train may be applied to more efficiently terminate the atrial arrhythmia.
    Type: Grant
    Filed: July 16, 2007
    Date of Patent: July 6, 2010
    Assignee: Pacesetter, Inc.
    Inventor: Pajhand Iranitalab